Supernus Pharmaceuticals SUPN Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from Supernus Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: Supernus Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Supernus Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Supernus Pharmaceuticals's operating margin?
- Supernus Pharmaceuticals (SUPN) reported operating margin of -7.8% in Q1 2026.
- How has Supernus Pharmaceuticals's operating margin changed year-over-year?
- Supernus Pharmaceuticals's operating margin decreased by 169.6% year-over-year, from 11.2% to -7.8%.
- What is the long-term trend for Supernus Pharmaceuticals's operating margin?
- Over 5 years (2020 to 2025), Supernus Pharmaceuticals's operating margin has grown at a -23.6% compound annual growth rate (CAGR), from 33.4% to -8.7%.
- What does operating margin mean?
- Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.